Skip to content

Clinical trials

Phase 4 Hemorrhage trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Phase: Phase 4 Country / region: United States Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20073
20081
20092
20114
20123
20132
20142
20156
20163
20174
20183
20193
20201
20212
20234
20242
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Terminated8
Recruiting5
Withdrawn4
Unknown status3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospital for Special Surgery, New York4
Oregon Health and Science University4
Brigham and Women's Hospital2
Duke University2
Northwestern University2
University of Florida2
Yale University2
Amjad Alwaal, MD, MSc, FRCSC, FACS1
Antonios Likourezos1
Beth Israel Deaconess Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage52
Blood Loss, Surgical3
Coronary Artery Disease3
Diabetes Insipidus3
Leiomyoma3
Thrombosis3
Atrial Fibrillation2
Hip Fractures2
Menorrhagia2
Metrorrhagia2

Trials

Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.